Previous 10 | Next 10 |
Thinly traded nano cap Pluristem Therapeutics (NASDAQ: PSTI ) spikes 55% premarket on increased volume in reaction to preliminary data on the use of its PLX cells in severely ill COVID-19 patients in Israel. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, S...
All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS) 100% survival rate for all seven patients 6 patients completed 1 week follow up; the seventh patient was treated on April 5 2020 4 of the 6 (66%) ...
Amarin (NASDAQ: AMRN ) -68% after court decision on Vascepa. More news on: Amarin Corporation plc, Delphi Technologies PLC, SuperCom Ltd., Stocks on the move, , Read more ...
Pluristem Therapeutics (NASDAQ: PSTI ) has dosed three patients in two different hospitals in Israel under a compassionate use program for the treatment of COVID-19. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read more ...
Expects to treat more patients in Israel in the coming days Company is in discussions with regulators in the U.S. and Europe to define its clinical strategy for COVID-19 HAIFA, Israel, March 30, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI)...
Pluristem Therapeutics (NASDAQ: PSTI ) issues an update, in response to coronavirus pandemic. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, Read more ...
HAIFA, Israel, March 26, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological products, today issued an update to its shareholders from its Chief Executive Officer and Presi...
The Israeli Ministry of Health has approved a request from Pluristem Therapeutics (NASDAQ: PSTI ) to seek a regulatory nod to use its PLX cell therapy to treat COVID-19 on a per-patient compassionate use basis in Israel. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, ...
BioNTech SE (NASDAQ: BNTX ) +55% on teaming up with Pfizer teams to develop COVID-19 vaccine. More news on: BioNTech SE, Co-Diagnostics, Inc., Neon Therapeutics, Inc., Stocks on the move, , Read more ...
HAIFA, Israel, March 17, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological products, today announced that the Israeli Ministry of Health has approved Pluristem’s ...
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...